Aurora Cannabis (TSE:ACB) Stock Price Up 0.2% – Here’s What Happened

Shares of Aurora Cannabis Inc. (TSE:ACB) shot up 0.2% on Wednesday . The stock traded as high as C$5.37 and last traded at C$5.34. Approximately 187,258 shares changed hands during mid-day trading, a decline of 55% from the average daily volume of 419,252 shares. The stock had previously closed at C$5.33.

Wall Street Analyst Weigh In

ACB has been the subject of several recent analyst reports. ATB Cormark Capital Markets downgraded Aurora Cannabis from an “outperform” rating to a “tender” rating and decreased their price target for the stock from C$6.50 to C$5.60 in a research note on Wednesday, August 19th. BMO Capital Markets upgraded Aurora Cannabis to a “hold” rating in a research note on Wednesday, August 5th. Canaccord Genuity Group cut their price objective on Aurora Cannabis from C$6.50 to C$5.00 and set a “buy” rating for the company in a report on Tuesday, June 30th. Finally, TD dropped their price target on Aurora Cannabis from C$10.00 to C$8.00 and set a “buy” rating for the company in a report on Friday, June 12th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of C$6.20.

Aurora Cannabis Price Performance

The company has a market cap of C$320.32 million, a P/E ratio of -2.66 and a beta of 0.42. The company has a fifty day moving average price of C$4.55 and a two-hundred day moving average price of C$4.63. The company has a debt-to-equity ratio of 4.30, a quick ratio of 2.48 and a current ratio of 5.36.

Aurora Cannabis (TSE:ACB) last issued its earnings results on Wednesday, August 5th. The company reported C($0.07) earnings per share (EPS) for the quarter. Aurora Cannabis had a negative net margin of 9.53% and a negative return on equity of 5.21%. The firm had revenue of C$67.55 million during the quarter. On average, sell-side analysts anticipate that Aurora Cannabis Inc. will post -0.22 earnings per share for the current fiscal year.

About Aurora Cannabis

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.